The phase III EFECT study 20 directly compared exemestane with fulvestrant, with a loading dose followed by low dose 500 mg on day 0, 250 mg on days 14 and 28, then 250 mg every 28 days priligy Community acquired methicillin resistant Staphylococcus aureus carrying Panton Valentine leukocidin genes worldwide emergence